References
- Rose N. The Politics of Life Itself: Biomedicine, Power and Subjectivity in the Twenty-First Century. Princeton University Press, NJ, USA (2007).
- Institute for Prospective Technological Studies. Pharmacogenetics and Pharmacogenomics: State of the Art and Potential Socio-economic Impact in the EU. Office for Official Publications of the European Communities, Luxembourg (2006).
- Nass S , MosesH. Cancer Biomarkers: the Promises and Challenges of Improving Detection and Treatment. Institute Of Medicine, Washington, DC, USA (2007).
- Webster A , MartinP, LewisG, SmartA. Integrating pharmacogenetics into society: in search of a model? Nat. Rev. Genet. 5(9)663–669 (2004).
- Liddell K , HogarthS, MelzerD, ZimmernR. Patents as incentives for translational and evaluative research: the case of genetic tests and their improved clinical performance. Intellectual Property Quarterly3, 286–327 (2008).
- Hogarth S. The Clinical Application of New Molecular Diagnostic Technologies – a Review of the Regulatory and Policy Issues, a Report to Health Canada. Cambridge University, Cambridge, UK (2007).
- US FDA . Innovation or Stagnation: Challenge and Opportunity on the Critical Path to New Medical Products. US Department of Health and Human Services, US FDA, Washington, DC, USA (2004).
- European Medicines Agency. The European Medicines Agency Road Map to 2010: Preparing the Ground for the Future. EMA, London, UK (2005).
- Abraham J , DavisC. Deficits, expectations and paradigms in British and American drug safety assessments: prising open the black box of regulatory science. Sci. Technol. Human Values32, 399–431 (2007).
- Sung NS , CrowleyWF Jr, GenelM. Central challenges facing the national clinical research enterprise. JAMA289, 1278–1287 (2003).
- Swen JJ , HuizingaTW, GelderblomH. Translating pharmacogenomics: challenges on the road to the clinic. PLoS Med.4(8), e209 (2007).
- Sussman S , ValenteTW, RohrbachLA, SkaraS, PentzMA. Translation in the health professions: converting science into action. Eval. Health Prof.29(1), 7–32 (2006).
- Khoury MJ , GwinnM, YoonPW, DowlingN, MooreCA, BradleyL. The continuum of translation research in genomic medicine: how can we accelerate the appropriate integration of human genome discoveries into health care and disease prevention? Genet. Med. 9(10), 665–674 (2007).
- Greenhalgh T , RobertG, MacfarlaneF, BateP, KyriakidouO. Diffusion of innovations in service organizations: systematic review and recommendations. Milbank Q.82(4), 581–629 (2004).
- Blume S. Insight and Industry: on the Dynamics of Technological Change in Medicine. MIT Press, MA, USA (1992).
- Hedgecoe A. The Politics of Personalised Personalized Medicine: Pharmacogenetics in the Clinic. Cambridge University Press, Cambridge, UK (2005).
- Parthasarathy S. Building Genetic Medicine: Breast Cancer, Technology, and the Comparative Politics of Health Care. MIT Press, MA, USA (2007).
- Martin P. Genes as drugs: the social shaping of genetherapy and the reconstruction of genetic disease. Sociol. Health Illn.21(5), 517–538 (1999).
- Hopkins M. The hidden research system: the evolution of cytogenetic testing in the National Health Service. Science Culture15(3), 253–276 (2006).
- Faulkner A. Resisting the screening imperative: patienthood, populations and politics in prostate cancer detection technologies for the UK. Sociol. Health Illn.doi:10.1111/j.1467–9566.01385.x (2011) (Epub ahead of print).
- Hogarth S , HopkinsM, RodriguezV. A molecular monopoly? HPV testing, the Pap smear and the molecularisation of cervical cancer screening in the USA. Sociol. Health Illn.doi:10.1111/j.1467-9566.01411.x2011 (2011) (Epub ahead of print).
- Dopson S , FitzgeraldL. Knowledge to Action: Evidence-based Healthcare in Context. Oxford University Press, Oxford, UK (2005).
- Swan J , GoussevskaiaA, NewellS, RobertsonM, BresnenM, ObembeaA. Modes of organizing biomedical innovation in the UK and US and the role of integrative and relational capabilities. Res. Policy36, 529–547 (2007).
- Swan J , BresnenM, NewellS, RobertsonM. The object of knowledge: the role of objects in interactive innovation. Hum. Relat.60(12), 1809–1837 (2007).
- Currie G , SuhomlinovaS. The impact of institutional forces upon knowledge sharing in the UK NHS: the triumph of professional power and the inconsistency of policy. Public Admin.84(1), 1–30 (2006).
- Robertson M. Translating breakthroughs in genetics into biomedical innovation: the case of UK Genetic Knowledge Parks. Technol. Analysis Strategic Management19(2), 189–204 (2007).
- Robert G , GreenhalghT, MacFarlaneF, PeacockR. Adopting and assimilating new non-pharmaeutical technologies into health care: a systematic review. J. Health Serv. Res. Policy15(4), 245–250 (2010).
- May C , FinchT. Implementing, embedding and integrating practices: an outline of normalization process theory. Sociology43(3), 535–554 (2009).
- Moors E , van der GiessenA, EnzingC, SmitsR. User-producer interactions in functional genomics innovations. Innovation: Management, Policy Practice5(2/3), 120–143 (2003).
- Clarke AE et al. Biomedicalization: technoscientific transformation of health, illness, and US biomedicine. Am. Sociolog. Rev.68(2), 161–194 (2003).
- Ayme S , MathjisG, SoniS. Patenting and licensing in genetic testing: recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet.16, S3–S9 (2008).
- Baldwin T. Ethics and patents for genetic diagnostic tests. In: Gene Patents and Public Health. van OverwalleG (Ed.). Bruylant, Brussels, Belgium (2007).
- Nuffiield Council on Bioethics. The Ethics of DNA Patenting. Nuffield Council on Bioethics, London, UK (2002).
- Secretary’s Advisory Committee on Genetics Health and Society. Report on Gene Patents and Licensing Practices and Their Impact on Patient Access to Genetic Tests. National Institutes of Health, Washington, DC, USA (2010).
- Organisation for Economic Cooperation and Development. Guidelines for the licensing of genetic inventions. Organisation for Economic Cooperation and Development, Paris, France (2006).
- Rose N , MarrisC. Open engagement: exploring public participation in the biosciences. PLoS Biol.8(11), e1000549 (2010).